98769-74-5 Usage
General Description
"(R*,R*)-3-Amino-1-(2-ethoxyphenoxy)-1-phenylpropan-2-ol" is a chemical compound that belongs to the class of beta-adrenergic receptor agonists. It is commonly used as a bronchodilator to treat conditions such as asthma, bronchitis, and other respiratory disorders. (R*,R*)-3-Amino-1-(2-ethoxyphenoxy)-1-phenylpropan-2-ol works by relaxing the muscles in the airways, making it easier to breathe. It is typically administered through inhalation and is known for its quick onset of action and effectiveness in relieving respiratory symptoms. However, like any medication, it may have potential side effects and contraindications, so it should be used under the supervision of a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 98769-74-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,7,6 and 9 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 98769-74:
(7*9)+(6*8)+(5*7)+(4*6)+(3*9)+(2*7)+(1*4)=215
215 % 10 = 5
So 98769-74-5 is a valid CAS Registry Number.
InChI:InChI=1/C17H21NO3/c1-2-20-15-10-6-7-11-16(15)21-17(14(19)12-18)13-8-4-3-5-9-13/h3-11,14,17,19H,2,12,18H2,1H3
98769-74-5Relevant articles and documents
Commercial synthesis of (S,S)-reboxetine succinate: A journey to find the cheapest commercial chemistry for manufacture
Hayes, Stewart T.,Assaf, Georges,Checksfield, Graham,Cheung, Chi,Critcher, Doug,Harris, Laurence,Howard, Roger,Mathew, Suju,Regius, Christian,Scotney, Gemma,Scott, Adam
experimental part, p. 1305 - 1314 (2012/01/14)
The development of a synthetic process for (S,S)-reboxetine succinate, a candidate for the treatment of fibromylagia, is disclosed from initial scale-up to deliver material for registrational stability testing through to commercial route evaluation and subsequent nomination. This entailed evaluation of several alternative routes to result in what would have been a commercially attractive process for launch of the compound.
Configurational studies on 2-[α-(2-ethoxyphenoxy)benzyl]morpholine FCE 20124
Melloni,Della Torre,Lazzari,et al.
, p. 1393 - 1399 (2007/10/02)
-